These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1325225)

  • 41. Functional alterations in GABAergic inhibition during activity.
    Prince DA; Deisz RA; Thompson SM; Chagnac-Amitai Y
    Epilepsy Res Suppl; 1992; 8():31-8. PubMed ID: 1384541
    [No Abstract]   [Full Text] [Related]  

  • 42. GABA-ergic drugs: exit stage left, enter stage right.
    Ashton H; Young AH
    J Psychopharmacol; 2003 Jun; 17(2):174-8. PubMed ID: 12870563
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New antiepileptic drugs: from serendipity to rational discovery.
    Porter RJ; Rogawski MA
    Epilepsia; 1992; 33 Suppl 1():S1-6. PubMed ID: 1379532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. GABA receptor mechanisms in the central nervous system.
    Sivilotti L; Nistri A
    Prog Neurobiol; 1991; 36(1):35-92. PubMed ID: 1847747
    [No Abstract]   [Full Text] [Related]  

  • 45. The pathophysiology of epileptic seizures: a primer for pediatricians.
    Stafstrom CE
    Pediatr Rev; 1998 Oct; 19(10):342-51. PubMed ID: 9785934
    [No Abstract]   [Full Text] [Related]  

  • 46. Stiripentol.
    Chiron C
    Neurotherapeutics; 2007 Jan; 4(1):123-5. PubMed ID: 17199026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The mechanisms of action of commonly used antiepileptic drugs.
    Kwan P; Sills GJ; Brodie MJ
    Pharmacol Ther; 2001 Apr; 90(1):21-34. PubMed ID: 11448723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-epileptic drugs.
    Howard P; Twycross R; Shuster J; Mihalyo M; RĂ©mi J; Wilcock A
    J Pain Symptom Manage; 2011 Nov; 42(5):788-804. PubMed ID: 22045376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cerebal overinhibition could be the basis for the high prevalence of epilepsy in persons with Down syndrome.
    Araujo BH; Torres LB; Guilhoto LM
    Epilepsy Behav; 2015 Dec; 53():120-5. PubMed ID: 26558714
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulation and polytypic signaling in GABAergic transmission.
    Schlichting JL
    Neurochem Res; 1990 Feb; 15(2):131-43. PubMed ID: 1970618
    [No Abstract]   [Full Text] [Related]  

  • 51. Targeting brain GABAA receptors with antisense oligonucleotides: implications for epilepsy.
    Karle J; Nielsen M
    Methods Enzymol; 2000; 314():20-32. PubMed ID: 10565002
    [No Abstract]   [Full Text] [Related]  

  • 52. [Neurochemical and pharmacological principles in the therapy of epilepsies].
    Cotrufo R; Bonavita V
    Acta Neurol (Napoli); 1976; 31(2):131-45. PubMed ID: 1007978
    [No Abstract]   [Full Text] [Related]  

  • 53. A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders.
    Jobe PC; Dailey JW; Wernicke JF
    Crit Rev Neurobiol; 1999; 13(4):317-56. PubMed ID: 11028680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic drug exposure downregulates GABAAergic transmission.
    Ticku MK; Mehta AK
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():687A-688A. PubMed ID: 1323415
    [No Abstract]   [Full Text] [Related]  

  • 55. Recent studies on the brain benzodiazepine receptor.
    Waddington JL
    Ir J Med Sci; 1984 Aug; 153(8):263-7. PubMed ID: 6092296
    [No Abstract]   [Full Text] [Related]  

  • 56. New drugs for epilepsy: a rapidly changing scene.
    Richens A
    Acta Neurol Scand Suppl; 1992; 140():65-70. PubMed ID: 1332363
    [No Abstract]   [Full Text] [Related]  

  • 57. Epileptogenesis, ictogenesis and the design of future antiepileptic drugs.
    Weaver DF
    Can J Neurol Sci; 2003 Feb; 30(1):4-7. PubMed ID: 12619776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The seizure mechanisms of an epileptic mutant animal.
    Suzuki J; Kasamo K; Ishida N; Murashima Y; Nakamoto Y; Ozawa N
    Jpn J Psychiatry Neurol; 1989 Sep; 43(3):455-7. PubMed ID: 2560495
    [No Abstract]   [Full Text] [Related]  

  • 59. Non-synaptic mechanisms that could be responsible for potential antiepileptic effects of omega-3 fatty acids.
    De Almeida AC; dos Santos HL; Rodrigues AM; Cysneiros RM; Cavalheiro EA; Arida RM; Scorza FA
    Epilepsy Behav; 2012 Sep; 25(1):138-40. PubMed ID: 22832612
    [No Abstract]   [Full Text] [Related]  

  • 60. Excitatory amino acids in epilepsy and potential novel therapies.
    Meldrum BS
    Epilepsy Res; 1992 Jul; 12(2):189-96. PubMed ID: 1327746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.